Trials / Completed
CompletedNCT00278135
Memory Improvement With Docosahexaenoic Acid Study (MIDAS)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in the Elderly
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 485 (actual)
- Sponsor
- dsm-firmenich Switzerland AG · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of docosahexaenoic acid (DHA, 22:6n-3) in improving cognitive functions in subjects with age-related cognitive decline. DHA is a long chain omega-3 fatty acid (LC-PUFA) that plays an important role in neural and visual development and cardiovascular health.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | DHA (nutritional supplement) or placebo | oral 900mg/day |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2008-10-01
- Completion
- 2008-12-01
- First posted
- 2006-01-18
- Last updated
- 2014-05-19
Locations
14 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00278135. Inclusion in this directory is not an endorsement.